(Q45829254)

16 December 2017

title

Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection (English)

1 reference

16 December 2017

1 reference

Hirota K

1

1 reference

16 December 2017

Sherker AH

2

1 reference

16 December 2017

Omata M

3

1 reference

16 December 2017

Yokosuka O

4

1 reference

16 December 2017

Okuda K

5

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

16 December 2017

published in

Hepatology

1 reference

16 December 2017

volume

7

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

24-28

1 reference

16 December 2017

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

Effects of Interferon and Adenine Arabinoside Treatment of Hepatitis B Virus Infection on Cellular Immune Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

Effect of Vidarabine on Chronic Hepatitis B Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Adenine arabinoside 5′-monophosphate treatment of chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: a study of viral DNA in serum and tissue

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Mechanism of DNA synthesis inhibition by arabinosyl cytosine and arabinosyl adenine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Experimental transmission of duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070107

7 January 2021

Identifiers

DOI

10.1002/HEP.1840070107

1 reference

16 December 2017

PubMed ID

3804202

1 reference

16 December 2017